Specialists for Genetic Susceptibility to Cancer
11 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.
ℹ
Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.
Report missing data- W. Marston Linehan, M.D.Rare Disease SpecialistNational Cancer Institute (NCI)Bethesda, MarylandPI×6
- Sharon A Savage, M.D.Rare Disease SpecialistNational Cancer Institute (NCI)Bethesda, MarylandPI×7
- Kim E. Nichols, MDRare Disease SpecialistSt. Jude Children's Research HospitalMemphis, TennesseePI×2
- Patricia L Dahia, MD, PhDRare Disease / Clinical ResearchThe University of Texas Health Science Center at San AntonioPI×2
- Anne-Paule Gimenez-Roqueplo, MD, PhDRare Disease / Clinical ResearchParis-Descartes University, Européen Georges Pompidou Hospital, Assistance Publique des Hôpitaux de ParisPI×2
- Patrick Lynch, MD, JDRare Disease / Clinical ResearchM.D. Anderson Cancer CenterPI×2
- Angela R Bradbury, MDUniversity of PennsylvaniaPHILADELPHIA, PAQC-verified PI×1
- Raheleh RahbariWellcome Sanger InstituteQC-verified PI×1
- Florent de VathaireInstitut National de la Santé Et de la Recherche Médicale, FranceQC-verified PI×1
- Evis Sala, M.D., Ph.DFondazione Policlinico Universitario A. Gemelli, IRCCSNEW YORK, NYQC-verified PI×1
- François GHIRINGHELLI, PU-PHCentre Georges Francois LeclercQC-verified PI×1